Friedreich Ataxia Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
Friedreich Ataxia Medications, Costs & Savings
Pharmacist insight
Anti-seizure medications require careful monitoring of blood levels to ensure therapeutic effectiveness. I advise patients never to switch between brand and generic without consulting their pharmacist, as even small differences in absorption can affect seizure control. Medication adherence is the single most important factor.
Angela C. Beverly, PharmD
About Friedreich Ataxia
Friedreich Ataxia (FA) is a rare, inherited neurological disorder that progressively affects coordination, speech, and heart function. While there's no cure, managing symptoms with medications and therapies is key. TheDrugClub helps individuals and families afford these vital treatments, ensuring access to necessary prescriptions without financial strain.
Friedreich Ataxia (FA) is a rare, progressive genetic disorder that causes damage to the nervous system. It's inherited, meaning it's passed down through families, and typically begins in childhood or adolescence. The condition primarily affects the cerebellum, spinal cord, and peripheral nerves, leading to a range of symptoms that worsen over time.
Individuals with FA often experience ataxia, which is a lack of coordination, making movements difficult and unsteady. Other common symptoms include speech problems (dysarthria), muscle weakness, fatigue, vision and hearing impairment, scoliosis (curvature of the spine), and heart problems like cardiomyopathy. Diabetes can also develop in some patients. Understanding these challenges is the first step toward effective management.
While there isn't a cure for Friedreich Ataxia, treatment focuses on managing symptoms and improving quality of life. This often involves a multi-faceted approach, including physical, occupational, and speech therapy to maintain mobility, function, and communication skills. Medications play a crucial role in addressing specific symptoms. For instance, drugs like ACE inhibitors or beta-blockers may be prescribed to manage heart conditions. Muscle relaxants can help with spasticity, and pain relievers address discomfort. A significant development in recent years is the FDA-approved medication omaveloxolone (Skyclarys), specifically designed to treat FA, which can be an expensive but impactful part of a patient's regimen.
Managing the costs of these essential prescriptions can be a significant burden for individuals and families living with Friedreich Ataxia. This is where TheDrugClub steps in. For a low monthly membership fee – just $19.9
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.
MedlinePlus overview of Friedreich Ataxia
Friedreich ataxia is an inherited disease that damages your nervous system. The damage affects your spinal cord and the nerves that control muscle movement in your arms and legs. Symptoms usually begin between the ages of 5 and 15. The main symptom is ataxia, which means trouble coordinating movements. Specific symptoms include:
Difficulty walking
Muscle weakness
Speech problems
Involuntary eye movements
Scoliosis (curving of the spine to one side)
Heart palpitations, from the heart disease which can happen along with Friedreich ataxia
People with Friedreich ataxia usually need a wheelchair 15 to 20 years after symptoms first appear. In severe cases, people become incapacitated. There is no cure. You can treat symptoms with medicines, braces, surgery, and physical therapy.
NIH: National Institute of Neurological Disorders and Stroke
Source: MedlinePlus, U.S. National Library of Medicine. MedlinePlus topic page. Topic date: 04/18/2006. MedlinePlus file date: 10/15/2026 02:30:37.
This information is educational and is not medical advice.